Did you know?

ChinaBio^® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

Free Report

State of China Life Science 2022

Free Content

Week in Review

In My Opinion

Free Articles

Subscriber Content

Ascentage Building Headquarters, R&D Center, Manufacturing Facility in Suzhou

publication date: Nov 22, 2019

Ascentage Pharma has broken ground on its 95 acre corporate campus, a combined global headquarters, R&D center and manufacturing facility, in Suzhou Industrial Park (SIP). The company says the new R&D center will house an expanded research team to drive discovery of new targeted drug candidates for its pipeline; enhance its research capabilities in translational medicine, biomarkers and clinical pharmacology; and boost the success rate of its drug development programs. The manufacturing facility will be built to comply with global cGMP standards and bring its products to global markets. More details....

Stock Symbol: (HK: 6855)

Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Click here to join.